The Situation
____________
A U.S.-based biopharmaceutical company specializing in cardiovascular products was preparing for significant shifts in their competitive landscape. With two new product approvals on the horizon and a major loss of exclusivity (LOE) approaching, the client faced dual pressures:
- New Market Entrants: Competitor products nearing approval posed a direct threat to established product lines.
- Generic Erosion: Anticipated LOE opened the door to generics, threatening pricing, revenue, and market share.
The client needed timely, actionable intelligence to anticipate competitor moves and protect their market position.
The Solution
____________
Sedulo Group designed and executed a Targeted Competitive Monitoring Program to deliver timely and actionable insights into competitor strategies and generic entry points. The tailored program included:
- Competitor Launch Monitoring: Sedulo performed in-depth primary and secondary research to track two specific competitors preparing for product launches. Intelligence included launch timelines, GTM strategies, and projected market impact.
- Generics Market Analysis: Sedulo identified likely generic manufacturers, mapped their API sourcing and supply chains, and delivered insight into expected pricing models and distribution approaches.
- Strategic Risk Identification: By contextualizing data gathered from public sources, market conversations, and supply chain intelligence, Sedulo revealed potential vulnerabilities and inflection points the client could act on.
The Success
____________
Armed with these insights, the client:
- Developed targeted counter-launch strategies to mitigate the impact of competitor product approvals
- Adjusted pricing, contracting, and distribution approaches to blunt the effects of generic erosion
- Safeguarded their market positioning amidst heightened competition